Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis

Published:2020-05-27 Issue:1 Volume:17 Page:35-50
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zhao Jun¹²^ORCID,Zhang Xiaoling¹^ORCID,Du Yunyi¹^ORCID,Zhou Lurong³^ORCID,Dong Ziming²⁴⁵,Zhao Jimin²⁴⁵^ORCID,Lu Jing²⁴⁵^ORCID

Affiliation:

1. Department of Oncology, Changzhi People’s Hospital, Changzhi, China

2. Department of Pathophysiology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China

3. Quality Control Department, Changzhi People’s Hospital, Changzhi, China

4. Collaborative Innovation Center of Henan Province for Cancer Chemoprevention, Zhengzhou, China

5. State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China

Funder

Natural Science Foundation of China

Scientific and Technological Innovation Team in Universities of Henan Province

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1759996

Reference51 articles.

1. Cancer statistics, 2018

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

4. Outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic NSCLC at US oncology practices

5. Anti-Angiogenics: Their Value in Lung Cancer Therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxic Postconditioning Promotes Angiogenesis After Ischemic Stroke;Neuroscience;2023-08

2. Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma;Journal of Immunology Research;2022-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3